Kenneth J. Hillan 23and Me Holding Co. (ME) insider trading activity
Kenneth J. Hillan is Chief Therapeutics Officer of 23andMe Holding Co.. Currently has a direct ownership of 221,876 shares of ME, which is worth approximately $703,346. The most recent transaction as insider was on Jun 05, 2023, when has been sold 15,347 shares (Class A Common Stock) at a price of $2.08 per share, resulting in proceeds of $31,921. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
222K
0%
3M change
0%
12M change
Total Value Held
$703,346
Kenneth J. Hillan Transaction History
Also insider at
KJH
Kenneth J. Hillan
Chief Therapeutics Officer
South San Francisco, CA